Literature DB >> 27302066

CerS6 Is a Novel Transcriptional Target of p53 Protein Activated by Non-genotoxic Stress.

Baharan Fekry1, Kristen A Jeffries1, Amin Esmaeilniakooshkghazi1, Besim Ogretmen2, Sergey A Krupenko3, Natalia I Krupenko4.   

Abstract

Our previous study suggested that ceramide synthase 6 (CerS6), an enzyme in sphingolipid biosynthesis, is regulated by p53: CerS6 was elevated in several cell lines in response to transient expression of p53 or in response to folate stress, which is known to activate p53. It was not clear, however, whether CerS6 gene is a direct transcriptional target of p53 or whether this was an indirect effect through additional regulatory factors. In the present study, we have shown that the CerS6 promoter is activated by p53 in luciferase assays, whereas transcriptionally inactive R175H p53 mutant failed to induce the luciferase expression from this promoter. In vitro immunoprecipitation assays and gel shift analyses have further demonstrated that purified p53 binds within the CerS6 promoter sequence spanning 91 bp upstream and 60 bp downstream of the transcription start site. The Promo 3.0.2 online tool for the prediction of transcription factor binding sites indicated the presence of numerous putative non-canonical p53 binding motifs in the CerS6 promoter. Luciferase assays and gel shift analysis have identified a single motif upstream of the transcription start as a key p53 response element. Treatment of cells with Nutlin-3 or low concentrations of actinomycin D resulted in a strong elevation of CerS6 mRNA and protein, thus demonstrating that CerS6 is a component of the non-genotoxic p53-dependent cellular stress response. This study has shown that by direct transcriptional activation of CerS6, p53 can regulate specific ceramide biosynthesis, which contributes to the pro-apoptotic cellular response.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ceramide synthase; lipid signaling; p53; transcription factor; transcription regulation

Mesh:

Substances:

Year:  2016        PMID: 27302066      PMCID: PMC4974374          DOI: 10.1074/jbc.M116.716902

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  PROMO: detection of known transcription regulatory elements using species-tailored searches.

Authors:  Xavier Messeguer; Ruth Escudero; Domènec Farré; Oscar Núñez; Javier Martínez; M Mar Albà
Journal:  Bioinformatics       Date:  2002-02       Impact factor: 6.937

2.  Activation of p21-Dependent G1/G2 Arrest in the Absence of DNA Damage as an Antiapoptotic Response to Metabolic Stress.

Authors:  L Alexis Hoeferlin; Natalia V Oleinik; Natalia I Krupenko; Sergey A Krupenko
Journal:  Genes Cancer       Date:  2011-09

Review 3.  Transcriptional regulation by p53: one protein, many possibilities.

Authors:  O Laptenko; C Prives
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

Review 4.  Membrane channels formed by ceramide.

Authors:  Marco Colombini
Journal:  Handb Exp Pharmacol       Date:  2013

Review 5.  Regulation of lipid metabolism by p53 - fighting two villains with one sword.

Authors:  Ido Goldstein; Varda Rotter
Journal:  Trends Endocrinol Metab       Date:  2012-07-20       Impact factor: 12.015

6.  Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents.

Authors:  R B Tishler; S K Calderwood; C N Coleman; B D Price
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

Review 7.  Diverse functions of ceramide in cancer cell death and proliferation.

Authors:  Sahar A Saddoughi; Besim Ogretmen
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

8.  Ferroptosis as a p53-mediated activity during tumour suppression.

Authors:  Le Jiang; Ning Kon; Tongyuan Li; Shang-Jui Wang; Tao Su; Hanina Hibshoosh; Richard Baer; Wei Gu
Journal:  Nature       Date:  2015-03-18       Impact factor: 49.962

Review 9.  Metabolic regulation by p53 family members.

Authors:  Celia R Berkers; Oliver D K Maddocks; Eric C Cheung; Inbal Mor; Karen H Vousden
Journal:  Cell Metab       Date:  2013-08-15       Impact factor: 27.287

10.  Ceramide Synthase 6 Is a Novel Target of Methotrexate Mediating Its Antiproliferative Effect in a p53-Dependent Manner.

Authors:  Baharan Fekry; Amin Esmaeilniakooshkghazi; Sergey A Krupenko; Natalia I Krupenko
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

View more
  21 in total

1.  Expression of the SNAI2 transcriptional repressor is regulated by C16-ceramide.

Authors:  Ping Lu; Shai White-Gilbertson; Rose Nganga; Mark Kester; Christina Voelkel-Johnson
Journal:  Cancer Biol Ther       Date:  2019-03-05       Impact factor: 4.742

Review 2.  Ceramide Signaling and p53 Pathways.

Authors:  Kristen A Jeffries; Natalia I Krupenko
Journal:  Adv Cancer Res       Date:  2018-06-01       Impact factor: 6.242

Review 3.  Sphingolipid metabolism in cancer signalling and therapy.

Authors:  Besim Ogretmen
Journal:  Nat Rev Cancer       Date:  2017-11-17       Impact factor: 60.716

4.  Receptor-interacting Ser/Thr kinase 1 (RIPK1) and myosin IIA-dependent ceramidosomes form membrane pores that mediate blebbing and necroptosis.

Authors:  Rose Nganga; Natalia Oleinik; Jisun Kim; Shanmugam Panneer Selvam; Ryan De Palma; Kristen A Johnson; Rasesh Y Parikh; Vamsi Gangaraju; Yuri Peterson; Mohammed Dany; Robert V Stahelin; Christina Voelkel-Johnson; Zdzislaw M Szulc; Erhard Bieberich; Besim Ogretmen
Journal:  J Biol Chem       Date:  2018-11-12       Impact factor: 5.157

5.  Ceramide-Rubusoside Nanomicelles, a Potential Therapeutic Approach to Target Cancers Carrying p53 Missense Mutations.

Authors:  Sachin K Khiste; Zhijun Liu; Kartik R Roy; Mohammad B Uddin; Salman B Hosain; Xin Gu; Sami Nazzal; Ronald A Hill; Yong-Yu Liu
Journal:  Mol Cancer Ther       Date:  2019-10-23       Impact factor: 6.261

Review 6.  Loss of ALDH1L1 folate enzyme confers a selective metabolic advantage for tumor progression.

Authors:  Sergey A Krupenko; Natalia I Krupenko
Journal:  Chem Biol Interact       Date:  2019-02-20       Impact factor: 5.192

7.  CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulation.

Authors:  Hanxiao Shi; Atsuko Niimi; Toshiyuki Takeuchi; Kazuya Shiogama; Yasuyoshi Mizutani; Taisuke Kajino; Kenichi Inada; Tetsunari Hase; Takahiro Hatta; Hirofumi Shibata; Takayuki Fukui; Toyofumi Fengshi Chen-Yoshikawa; Kazuki Nagano; Takashi Murate; Yoshiyuki Kawamoto; Shuta Tomida; Takashi Takahashi; Motoshi Suzuki
Journal:  Cancer Sci       Date:  2021-05-04       Impact factor: 6.716

Review 8.  Sphingolipids and the link between alcohol and cancer.

Authors:  Keri A Barron; Kristen A Jeffries; Natalia I Krupenko
Journal:  Chem Biol Interact       Date:  2020-03-11       Impact factor: 5.192

Review 9.  A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis.

Authors:  Brianna M Quinville; Natalie M Deschenes; Alex E Ryckman; Jagdeep S Walia
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

Review 10.  The Role of Ceramide Metabolism and Signaling in the Regulation of Mitophagy and Cancer Therapy.

Authors:  Megan Sheridan; Besim Ogretmen
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.